William K Heiden's Net Worth

$11.8 Million

Estimate Recalculated Sep 11, 2024 09:06PM EST

Who is William K Heiden

William K Heiden has an estimated net worth of $11.8 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., AMAG PHARMACEUTICALS INC., MACROGENICS INC, GTC BIOTHERAPEUTICS INC, and PRAECIS PHARMACEUTICALS INC.

SEC CIK

William K Heiden's CIK is 0001214939

Past Insider Trading and Trends

2017 was William K Heiden's most active year for acquiring shares with 7 total transactions. William K Heiden's most active month to acquire stocks was the month of April. 2015 was William K Heiden's most active year for disposing of shares, totalling 13 transactions. William K Heiden's most active month to dispose stocks was the month of January. 2015 saw William K Heiden paying a total of $1,039,200.00 for 245,500 shares, this is the most they've acquired in one year. In 2015 William K Heiden cashed out on 128,727 shares for a total of $7,538,098.42, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Atara Biotherapeutics, Inc.

Investor
Updated Apr 02, 2024
Form 4
71.77%
150.00K
Apr 02, 2024
359.00K
Grant
Mar 31
Form 4
91.74%
100.00K
$0.25
$25.33K
Nov 14, 2023
209.00K
Purchase
Nov 10
Form 4
262.50%
136.50K
Jun 02, 2023
188.50K
Grant
May 31
Form 4
165.08%
52.00K
Jun 27, 2022
83.50K
Grant
Jun 23
Form 4
139.02%
28.50K
Jun 09, 2021
49.00K
Grant
Jun 08
Form 4
260.00%
32.50K
Jun 17, 2020
45.00K
Grant
Jun 16
Form 4
200.00%
17.00K
Jul 01, 2019
25.50K
Grant
Jun 27
Form 4
92.86%
6.50K
Jun 18, 2018
13.50K
Grant
Jun 14
Form 4
1,325.00%
26.50K
Jun 12, 2017
28.50K
Grant
Jun 08
Form 4
7.50K
Jan 05, 2017
7.50K
Grant
Jan 03
Form 4
10.50K
Jan 05, 2016
10.50K
Grant
Jan 04
Form 4
15.50K
Nov 25, 2015
15.50K
Grant
Nov 23
Form 3
Nov 25, 2015
Showing 13 results

AMAG PHARMACEUTICALS, INC.

President & CEO
Updated Mar 04, 2020
Form 4
-1.04%
-4.45K
$7.75
-$34.50K
Mar 04, 2020
424.61K
Tax
Mar 02
Form 4
-1.22%
-5.99K
$9.17
-$54.93K
Feb 25, 2020
484.06K
Tax
Feb 23 - Feb 25
Form 4
2.08%
10.00K
$10.70
$107.00K
May 09, 2019
490.06K
Purchase
May 09
Form 4
-1.64%
-8.00K
$14.76
-$118.11K
Mar 05, 2019
480.06K
Tax
Mar 01 - Mar 02
Form 4
71.68%
233.00K
Feb 27, 2019
558.06K
Grant
Feb 25
Form 4
-0.90%
-2.96K
$15.51
-$45.86K
Feb 26, 2019
325.06K
Tax
Feb 23
Form 4
-1.50%
-5.00K
$25.00
-$125.00K
Aug 08, 2018
328.02K
Sale
ScheduledAug 07
Form 4
-5.67%
-20.00K
$25.00
-$500.00K
Jun 05, 2018
333.02K
Sale
ScheduledJun 04
Form 4
66.21%
180.45K
$21.00
-$221.47K
Mar 06, 2018
453.02K
Grant
Mar 02
Form 4
-6.54%
-19.09K
$18.55
-$354.03K
May 10, 2017
272.56K
Tax
May 08
Form 4
72.59%
150.00K
Feb 27, 2017
356.65K
Grant
Feb 23
Form 4
6.06%
11.81K
$18.27
$215.81K
May 17, 2016
206.65K
Tax
May 16
Form 4
51.18%
102.74K
$26.94
-$492.04K
Mar 01, 2016
303.46K
Grant
Feb 26 - Mar 01
Form 4
-0.99%
-2.00K
$39.69
-$79.38K
Oct 02, 2015
200.72K
Sale
ScheduledOct 01
Form 4
-0.98%
-2.00K
$61.19
-$122.38K
Sep 02, 2015
202.72K
Sale
ScheduledSep 01
Form 4
-0.97%
-2.00K
$64.53
-$129.06K
Aug 05, 2015
204.72K
Sale
ScheduledAug 03
Form 4
-4.58%
-20.00K
$44.00
-$1.24M
Jul 17, 2015
416.72K
Sale
ScheduledJul 15
Form 4
-0.96%
-2.00K
$69.41
-$138.82K
Jul 02, 2015
206.72K
Sale
ScheduledJul 01
Form 4
13.78%
53.13K
$41.45
-$3.90M
Jun 08, 2015
438.72K
Sell-Options
ScheduledJun 05
Form 4
-5.01%
-11.38K
$67.77
-$771.09K
Jun 04, 2015
215.60K
Tax
Jun 02
Form 4
-1.08%
-2.47K
$49.70
-$122.96K
Mar 05, 2015
226.97K
Tax
Mar 03
Form 4
45.12%
90.00K
Feb 27, 2015
289.45K
Grant
Feb 26
Form 4
-4.72%
-9.89K
$40.49
-$400.45K
Dec 18, 2014
199.45K
Tax
Dec 17
Form 4
23.62%
40.00K
Aug 21, 2014
209.34K
Grant
Aug 19
Form 4
71.16%
109.40K
Feb 28, 2014
263.14K
Grant
Feb 27
Form 4
$12.99
$129.90K
May 28, 2013
443.74K
Options
May 24
Form 4
-5.37%
-8.16K
$25.03
-$204.29K
May 15, 2013
143.74K
Options
May 14
Form 4
1,282.00%
128.20K
Mar 04, 2013
138.20K
Grant
Feb 28
Form 4
10.00K
May 29, 2012
10.00K
Purchase
May 24 - May 25
Form 4
400.00K
May 16, 2012
400.00K
Grant
May 14
Form 3
May 16, 2012
Showing 31 results

MACROGENICS INC

Investor
Updated May 23, 2024
Form 4
23.00K
May 23, 2024
23.00K
Grant
May 21
Form 4
May 22, 2024
4.50K
Options
May 20
Form 4
23.50K
Jun 02, 2023
23.50K
Grant
May 31
Form 4
36.00K
May 24, 2022
36.00K
Grant
May 23
Form 3
May 24, 2022
Showing 5 results

GTC BIOTHERAPEUTICS INC

Chairman, President and CEO
Updated Jun 17, 2010
Form 4
300.00K
Jun 17, 2010
300.00K
Grant
Jun 15
Form 4
3.00K
Oct 05, 2009
3.00K
Grant
Oct 01
Form 3
Oct 05, 2009
Showing 3 results

PRAECIS PHARMACEUTICALS INC

President and COO
Updated Jan 16, 2004
Form 4
$3.58
$35.80K
Jan 16, 2004
602.00K
Options
Jan 15
Form 4
120.00K
Nov 14, 2003
132.00K
Grant
Nov 13
Showing 2 results